UChicago Medicine Comprehensive Cancer Center

Which Types of Metastatic Cancer Respond to Aggressive Treatment?

If you have metastatic cancer that includes any type of solid tumor, we may be able to offer you treatments designed to control or eliminate your disease. This includes:

For example, our cancer experts published a study that found that a subgroup of patients with colorectal cancer with liver metastasis who are identified through sophisticated genetic testing can be cured following aggressive treatment.

More Options for Some Patients with Limited Metastatic Cancer

At the UChicago Medicine Limited Metastatic Cancer Program, we can provide more promising treatments than most hospitals for patients with a state of metastatic cancer called oligometastasis. In oligometastasis, metastatic tumors have only spread to a few organs and are limited in number. For many patients with oligometastatic cancer, long-term survival may be possible with a combination of therapies including chemotherapy, targeted therapy, immunotherapy, radiation and surgery.

Even more promising treatments for metastatic cancer are becoming available at a rapid pace. Because physicians at UChicago Medicine are actively researching these therapies, you have access to the most advanced medical, surgical and radiation oncology treatments — before they are available elsewhere.

Biomarker Testing for Cancer Treatment

We know from our research that certain types of metastatic tumors are more likely to respond to curative treatment than others. Whenever possible, our physicians will conduct genetic testing on each of your tumors (also called biomarker testing, genomic testing or tumor subtyping) to tailor your treatment to your tumors and improve your chances of a successful outcome. Our expert pathologists offer a full range of molecular and genomic tests used to inform cancer treatment plans.

Convenient Locations for Cancer Care

Request an Appointment

We are currently experiencing a high volume of inquiries, leading to delayed response times. For faster assistance, please call 1-855-702-8222 to schedule your appointment.

If you have symptoms of an urgent nature, please call your doctor or go to the emergency room immediately.

For Referring Physicians

To refer a patient to the Limited Metastatic Cancer Program, please call 855-702-8222.

By submitting this form you acknowledge the risk of sending this information by email and agree not to hold the University of Chicago or University of Chicago Medical Center liable for any damages you may incur as a result of the transfer or use of this information. The use or transmittal of this form does not create a physician-contact relationship. More information regarding the confidentiality of this request can be found in our Privacy Policy.

* Indicates required field

Limited Metastatic Cancer Program (L-MEC)
Select option
By submitting this form you acknowledge the risk of sending this information by email and agree not to hold the University of Chicago or University of Chicago Medical Center liable for any damages you may incur as a result of the transfer or use of this information. The use or transmittal of this form does not create a physician-contact relationship. More information regarding the confidentiality of this request can be found in our Privacy Policy.